Cardiovascular Systems logo
Cardiovascular Systems CSII

Quarterly report 2022-Q4
added 02-09-2023

report update icon

Cardiovascular Systems Net Debt 2011-2026 | CSII

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Cardiovascular Systems

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-64.6 M -68.9 M - -53.3 M -95.2 M -86.8 M -60.6 M -83.8 M -124 M -55.3 M -18 M -9.02 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-9.02 M -124 M -65.4 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Medical devices industry

Issuer Net Debt Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
38.7 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-230 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-32.4 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
14.2 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-3.31 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
6.46 M - -5.86 % $ 30.6 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
252 K - 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
-26.2 M - - $ 16.4 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-4.29 M $ 1.35 - $ 21.8 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-22.5 M - - $ 475 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
78.5 M $ 11.72 -1.26 % $ 464 M curacaoCuracao
LENSAR LENSAR
LNSR
-13.6 M $ 5.56 -8.4 % $ 64 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
230 M - -4.14 % $ 702 M usaUSA
AxoGen AxoGen
AXGN
15.2 M $ 32.61 2.71 % $ 1.5 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
802 M $ 36.56 -0.19 % $ 1.13 B usaUSA
Penumbra Penumbra
PEN
-152 M $ 334.17 -0.41 % $ 13 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-31.6 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.02 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-2.3 M - 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
-10.5 M $ 24.7 0.86 % $ 209 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
5.72 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
-4.95 M - - $ 111 M canadaCanada
Insulet Corporation Insulet Corporation
PODD
468 M $ 225.5 -0.7 % $ 15.9 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.8 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
11.2 M $ 0.7 3.3 % $ 38.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
-4.85 M $ 2.16 -6.09 % $ 3.37 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
-7.36 M $ 5.15 -4.63 % $ 180 M canadaCanada
BIOLASE BIOLASE
BIOL
6.1 M - -13.19 % $ 166 K usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
7.4 M $ 3.82 -3.05 % $ 163 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
1.64 B $ 11.48 10.7 % $ 1.55 B usaUSA
Myomo Myomo
MYO
-4.79 M $ 0.7 -1.83 % $ 29.3 M usaUSA
Invacare Corporation Invacare Corporation
IVC
299 M - - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-22.8 M $ 3.91 4.83 % $ 146 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
83.3 M $ 15.91 -3.4 % $ 373 M usaUSA
Outset Medical Outset Medical
OM
63 M $ 3.53 -2.35 % $ 53.7 K usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
-433 M $ 52.07 -0.17 % $ 1.53 B usaUSA
Sintx Technologies Sintx Technologies
SINT
-898 K $ 2.57 0.78 % $ 7.13 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
-31.6 M $ 1.31 -5.76 % $ 53.3 M usaUSA
Cutera Cutera
CUTR
-140 M - -10.19 % $ 1.99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
1.8 M - 14.99 % $ 929 K usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
-21.6 M $ 3.96 -3.65 % $ 64.7 M usaUSA
InspireMD InspireMD
NSPR
-5.65 M $ 1.79 3.47 % $ 115 M israelIsrael
Eargo Eargo
EAR
-97.8 M - - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
-238 M - - $ 2.07 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
961 K - -0.97 % $ 54.4 M usaUSA